Jeff marrazzo spark therapeutics
WebJeffrey D. Marrazzo is co-founder and CEO of Spark Therapeutics, Inc. (NASDAQ: ONCE), a gene therapy leader developing one-time, life-altering treatments to transform the lives of … WebSpark Therapeutics, Inc. Type: Subsidiary of Hoffmann-La Roche: Industry: Biotechnology Pharmaceutical: Founded: 2013; 10 years ago () Founders: Katherine A. High Jeffrey …
Jeff marrazzo spark therapeutics
Did you know?
WebAug 18, 2024 · Jeff’s successful orchestration of Spark’s $4.8 billion sale to Roche in 2024 (including gaining antitrust clearances) marked a 100-fold increase in the company’s market value over 6 years and delivered $750 million in financial returns to Spark’s atypical founding investor, CHOP. Prior to Spark, Jeff helped build the first genetic ... WebMar 30, 2024 · As co-founder and CEO of Spark, Mr. Marrazzo created a fully integrated, commercial gene therapy company that successfully delivered to patients the world’s first gene therapy approved by both the FDA and EMA, while also discovering and developing potential treatments and cures for inherited retinal disease and rare bleeding and …
WebFeb 24, 2024 · Jeffrey D. Marrazzo, the co-founder of Spark Therapeutics, guided the company to the launch of the world’s first regulatory-approved gene therapy for genetic diseases and helmed the company’s merger with Swiss pharma giant Roche. Now, he is stepping down from his role as CEO. Ron Philip, Spark’s COO, will take over the role. WebSpark Therapeutics Announces Departure of CEO and Founder Jeff Marrazzo; COO Ron Philip Named as Successor Read More Spark Therapeutics Announces Updated Phase …
WebDec 17, 2024 · Spark Therapeutics Announces Updated Phase 1/2 Study Results Supporting the Durability of Investigational Gene Therapy SPK-8011 in Patients With Hemophilia A Dec 12, 2024 Chroma Medicine Welcomes Spark Therapeutics Co-Founder and Former Founding CEO Jeff Marrazzo to Board of Directors Oct 4, 2024 Report incorrect company … WebJeff Marrazzo Former CEO Spark Therapeutics Oftentimes, the many remaining challenges can be solved by bringing together different scientists and approaches in a partnership. …
WebDec 17, 2024 · Jeffrey Marrazzo owns about 305,000 units of Spark Therapeutics, Inc common stock. In the last 4 years at Spark Therapeutics, Inc, Jeffrey Marrazzo has sold …
WebJeff Marrazzo Co-founder and Former Founding CEO and Board Member, Spark Therapeutics Jeff founded and built Spark Therapeutics into the world’s first fully … powerball enero 22 2022WebDec 17, 2024 · Jeff Marrazzo admitted to mixed emotions Tuesday as Roche closed its $4.3 billion acquisition of Spark Therapeutics, the gene therapy company he co-founded and led as CEO for the past... powerball epWebOct 4, 2024 · CAMBRIDGE, Mass., Oct. 4, 2024 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing … powerball epicondiliteWebFeb 23, 2024 · Jeff Marrazzo, co-founder of Spark Therapeutics, will depart as the Philadelphia company's chief executive officer on April 1. Ron Philip, Spark's chief … powerball enter my numbersWebVerve Therapeutics Jeff Marrazzo Co-founder and former CEO Spark Therapeutics Chi-Ting Huang Vice President CMC Pheon Therapeutics Samantha Truex CEO Upstream Bio Alicia J. Hager Chief Legal Officer Nkarta Hilary Malone CEO Certego Therapeutics Greg Naeve Chief Business Officer RootPath Genomics Catherine Stehman-Breen CEO Chroma Medicine powerball entry codeWebFeb 23, 2024 · Jeffrey Marrazzo, CEO of gene therapy developer Spark Therapeutics, will step down as head of the company he co-founded almost nine years ago, steered to a historic Food and Drug Administration approval in 2024 and later led through a $4.3 billion buyout by Roche. Marrazzo will depart on April 1, Spark said Wednesday. towers of hope churchWebDec 17, 2024 · “Through this significant investment and plans to more than double our physical footprint, we're poised for continued growth as we seek to develop the next generation of genetic medicines as a member of the Roche Group,” said Jeff Marrazzo, chief executive officer and co-founder, of Spark Therapeutics. power ballers